| Independent risk factors and natural history of renal dysfunction in liver transplant recipients A Pawarode, DM Fine, PJ Thuluvath Liver transplantation 9 (7), 741-747, 2003 | 313 | 2003 |
| Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States L Muffly, MC Pasquini, M Martens, R Brazauskas, X Zhu, K Adekola, ... Blood, The Journal of the American Society of Hematology 130 (9), 1156-1164, 2017 | 241 | 2017 |
| An early-biomarker algorithm predicts lethal graft-versus-host disease and survival MJ Hartwell, U Özbek, E Holler, AS Renteria, H Major-Monfried, P Reddy, ... JCI insight 2 (3), 2017 | 237 | 2017 |
| Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients A Pawarode, N Voravud, V Sriuranpong, P Kullavanijaya, YZ Patt American journal of clinical oncology 21 (4), 386-391, 1998 | 211 | 1998 |
| MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD H Major-Monfried, AS Renteria, A Pawarode, P Reddy, F Ayuk, E Holler, ... Blood, The Journal of the American Society of Hematology 131 (25), 2846-2855, 2018 | 190 | 2018 |
| Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell … SW Choi, T Braun, L Chang, JLM Ferrara, A Pawarode, JM Magenau, ... The lancet oncology 15 (1), 87-95, 2014 | 147 | 2014 |
| Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation TS Fenske, KW Ahn, TM Graff, A DiGilio, Q Bashir, RT Kamble, E Ayala, ... British journal of haematology 174 (2), 235-248, 2016 | 143 | 2016 |
| Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes AC Harris, CL Kitko, DR Couriel, TM Braun, SW Choi, J Magenau, ... Haematologica 98 (2), 179, 2013 | 109 | 2013 |
| Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins A Pawarode, S Shukla, H Minderman, SM Fricke, EM Pinder, ... Cancer chemotherapy and pharmacology 60, 179-188, 2007 | 100 | 2007 |
| α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease JM Magenau, SC Goldstein, D Peltier, RJ Soiffer, T Braun, A Pawarode, ... Blood, The Journal of the American Society of Hematology 131 (12), 1372-1379, 2018 | 98 | 2018 |
| Intravenous busulfan compared with total body irradiation pretransplant conditioning for adults with acute lymphoblastic leukemia P Kebriaei, C Anasetti, MJ Zhang, HL Wang, I Aldoss, M de Lima, ... Biology of blood and marrow transplantation 24 (4), 726-733, 2018 | 78 | 2018 |
| Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: a CIBMTR report JR Schriber, PN Hari, KW Ahn, M Fei, LJ Costa, MA Kharfan‐Dabaja, ... Cancer 123 (16), 3141-3149, 2017 | 78 | 2017 |
| Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis AS Kanate, A DiGilio, KW Ahn, M Al Malki, E Jacobsen, A Steinberg, ... British journal of haematology 182 (6), 916, 2018 | 75 | 2018 |
| Survival following allogeneic transplant in patients with myelofibrosis K Gowin, K Ballen, KW Ahn, ZH Hu, H Ali, MO Arcasoy, R Devlin, ... Blood advances 4 (9), 1965-1973, 2020 | 70 | 2020 |
| TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomes SW Choi, P Stiff, K Cooke, JLM Ferrara, T Braun, C Kitko, P Reddy, ... Biology of blood and marrow transplantation 18 (10), 1525-1532, 2012 | 70 | 2012 |
| Infectious risk after allogeneic hematopoietic cell transplantation complicated by acute graft-versus-host disease HK Miller, TM Braun, T Stillwell, AC Harris, S Choi, J Connelly, D Couriel, ... Biology of Blood and Marrow Transplantation 23 (3), 522-528, 2017 | 66 | 2017 |
| Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT SW Choi, T Braun, I Henig, E Gatza, J Magenau, B Parkin, A Pawarode, ... Blood, The Journal of the American Society of Hematology 130 (15), 1760-1767, 2017 | 61 | 2017 |
| Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies J Magenau, H Tobai, A Pawarode, T Braun, E Peres, P Reddy, C Kitko, ... Blood, The Journal of the American Society of Hematology 118 (15), 4258-4264, 2011 | 61 | 2011 |
| Outcomes of primary hepatocellular carcinoma treatment: An 8‐year experience with 368 patients in Thailand A Pawarode, P Tangkijvanich, N Voravud Journal of gastroenterology and hepatology 15 (8), 860-864, 2000 | 54 | 2000 |
| Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysis A Mahindra, P Hari, R Fraser, M Fei, J Huang, J Berdeja, N Callander, ... Bone marrow transplantation 52 (12), 1616-1622, 2017 | 52 | 2017 |
